MD Medical Group Investments Plc

LSE:MDMG Stock Report

Mkt Cap: US$428.2m

We’ve recently updated our valuation analysis.

MD Medical Group Investments Valuation

Is MDMG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDMG?

Other financial metrics that can be useful for relative valuation.

MDMG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA3.3x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does MDMG's PE Ratio compare to its peers?

The above table shows the PE ratio for MDMG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average55.8x
SPI Spire Healthcare Group
MDC Mediclinic International
IDHC Integrated Diagnostics Holdings
MDMG MD Medical Group Investments

Price-To-Earnings vs Peers: MDMG is good value based on its Price-To-Earnings Ratio (5.9x) compared to the peer average (55.8x).

Price to Earnings Ratio vs Industry

How does MDMG's PE Ratio compare vs other companies in the European Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a19.1%

Price-To-Earnings vs Industry: MDMG is good value based on its Price-To-Earnings Ratio (5.9x) compared to the European Healthcare industry average (15.2x)

Price to Earnings Ratio vs Fair Ratio

What is MDMG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDMG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio5.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MDMG's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of MDMG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MDMG ($5.7) is trading below our estimate of fair value ($11.08)

Significantly Below Fair Value: MDMG is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies